Shares of Alto Neuroscience, Inc. (ANRO) have gained 162.9% over the past four weeks to close the last trading session at $10.2, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$13 indicates a potential upside of 27.5%.The mean estimate comprises seven short-term price targets with a standard deviation of $2.45. While the lowest estimate of$10.00 indicates a 2% decline from the ...